Natera

07/28/2026

This episode of JHLT: The Podcast features Katelynn S. Madill-Thomsen, Ph.D. and Philip F. Halloran, M.D., Ph.D., both from the Alberta Transplant Applied Genomics Center in Canada. They discuss results from the Trifecta-Heart study and changes to clinical practice based on the findings, including innovations from the kidney transplant community.

🎧 Listen to episode 87 of JHLT: The Podcast now to hear the full breakdown: https://ow.ly/xTQE50Zu0v6

JHLT: The Podcast returns for July with a paper entitled “,” available online now and in the July print issue of JHLT. Today’s guests are first author Katelynn S. Madill-Thomsen, PhD and senior author Philip F. Halloran, MD, PhD, both from the Alberta Transplant Applied Genomics Center in Cana...

07/25/2026

This World IVF Day and World Embryologist Day, we want to take a moment to recognize the embryologists, lab professionals, and clinicians who make it possible for individuals to have a chance at building their families through IVF.

Natera is honored to partner with the fertility community in advancing reproductive health.

07/15/2026

Some of the most meaningful progress in cancer research happens when science, care teams, and communities come together to support patients. Natera is proud to support Ride Audaxity and the work of the Medical College of Wisconsin Cancer because we believe in finding new ways to bring personalized insights and tailored care to patients with cancer.

We’re honored to be part of this bike ride, which takes place on August 2nd, and to support the research it helps to advance. Good luck to all the amazing riders!

A leader in DNA-based testing and precision medicine, Natera has committed to Audaxity as a title sponsor, backing the mission to accelerate cancer research across Wisconsin​.​ ​Natera, the company ​behind​ the Signatera​ ​test that helps detect signs of remaining or recurring cancer,....

07/08/2026

Throughout her journey from heart failure diagnosis to heart transplant, Nicole didn’t let anything stop her from pursuing her dreams. “I wanted to persevere and show other people that just because you have this diagnosis does not mean your life is over. I think that that mindset really helped me to not only survive what I had been through but to continue to really live,” she shared.

After her heart transplant, it was discovered that the routine biopsies Nicole received to monitor the health of the transplant were triggering complications with her new heart. Her care team turned to our Prospera™ Heart transplant assessment test - a simple blood draw that measures the amount of cell-free donor DNA from the transplanted organ in a patient's blood - to monitor organ rejection non-invasively. This also allowed Nicole to get her blood drawn at home, rather than traveling to the hospital, and ultimately decreased the number of biopsies she received. Want to learn more about Prospera for transplant patients? Click here:

06/21/2026

This Father's Day, we recognize the dads, stepdads, grandfathers, uncles, mentors, and all those who have been a steady, caring presence in someone's life.

Whether you coach from the sidelines, offer a listening ear, or simply lead by example, that kind of love and guidance leaves a lasting mark.

For anyone who may find this time of year difficult, we're thinking of you. 💙

06/12/2026

We’re honored to share that GO2 for Lung Cancer recently presented the 2026 Conquer Cancer–GO2 for Lung Cancer Young Investigator Award in memory of our colleague, Debbie Consiglio. Debbie was a valued member of the Natera team who passed away last year after living with small cell lung cancer. Her experience with cancer and Signatera™ MRD testing continues to inspire the work we do every day.

Dr. Jennifer W. Li from Johns Hopkins University received the award, which was presented by GO2 in partnership with Conquer Cancer®, the ASCO Foundation. With this one-year grant, Dr. Li will continue cancer research aimed at contributing to more personalized and more effective treatment strategies for people living with lung cancer. Congratulations, Dr. Li!

We’re so grateful to GO2 for this wonderful tribute to Debbie’s legacy. https://ow.ly/Hwy550Zbm6b

The group photo on the left below shows Dr. Li (center) with members of the GO2 team and the photo on the right is Debbie.

06/07/2026

Cancer survivorship looks different for everyone. And we all know someone living it - they’re our colleagues, neighbors, friends, and family.

Talking about survivorship can be powerful, and this National Cancer Survivors Day, we’re honoring that. Several members of our Natera team are cancer survivors. Others have walked alongside loved ones as they navigate what it means to be a survivor. Those experiences shape the work we do every day. Each action helps raise awareness about early detection and survivorship support available to those in your circle.

If you or someone you know is navigating life after a cancer diagnosis, you're not alone.

Hear more from patients living life after diagnosis here: https://ow.ly/LKfq50Z8vGK

05/19/2026

Carrier screening can support earlier diagnosis and family preparedness for conditions such as cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and sickle cell anemia.

Carrier screening can be performed either before or during pregnancy.

You can find more info on Horizon™ genetic carrier screening right here: https://ow.ly/umUj50Z1MPN

05/18/2026

At 66, Jon was diagnosed with muscle-invasive bladder cancer and given a prognosis measured in months. After treatment and scans, Jon and his care team added Signatera™ personalized molecular residual disease (MRD) testing to his recurrence monitoring and it became his "beacon" through survivorship.

See Jon's full story and learn more about personalized MRD testing here: https://ow.ly/rQ4x50Z1gRh

04/25/2026

In honor of Awareness Month, we're sharing the story of Dr. James Duke, a retired orthopedic surgeon, who was diagnosed with squamous cell carcinoma. His story is a powerful reminder of the importance of community and that informed patients can shape their outcomes.

Learn more: https://ow.ly/V74y50YNsm3